Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT01767311

Public ClinicalTrials.gov record NCT01767311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

Study identification

NCT ID
NCT01767311
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
856 participants

Conditions and interventions

Interventions

  • Lecanemab 10 mg/kg Drug
  • Lecanemab 2.5 mg/kg Drug
  • Lecanemab 5.0 mg/kg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2012
Primary completion
Dec 9, 2024
Completion
Dec 9, 2024
Last update posted
Mar 3, 2026

2012 – 2024

United States locations

U.S. sites
91
U.S. states
27
U.S. cities
73
Facility City State ZIP Site status
Facility #1 Birmingham Alabama 35294
Facility #1 Phoenix Arizona 85004
Facility #1 Tucson Arizona 85724
Facility #1 Carson California 90746
Facility #1 Lomita California 90717
Facility #1 Long Beach California 90806
Facility #1 Los Alamitos California 90720
Facility #1 Los Angeles California 90024
Facility #2 Los Angeles California 90024
Facility #3 Los Angeles California 90024
Facility #1 Orange California
Facility #1 Oxnard California 93030
Facility #1 San Diego California 92123
Facility #1 Denver Colorado 80239-3133
Facility #1 New Haven Connecticut 06510
Facility #2 New Haven Connecticut 06510
Facility #1 Atlantis Florida 33462
Facility #1 Boca Raton Florida 33431
Facility #2 Boca Raton Florida 33486
Facility #1 Bradenton Florida 34205
Facility #1 Deerfield Beach Florida 33064
Facility #1 Delray Beach Florida 33445
Facility #1 Fort Myers Florida 33912
Facility #1 Hallandale Florida 33009
Facility #1 Hialeah Florida 33016
Facility #1 Lake Worth Florida 33449
Facility #1 Leesburg Florida 34748
Facility #2 Leesburg Florida 34749
Facility #1 Miami Florida 33133
Facility #2 Miami Florida 33137
Facility #3 Miami Florida 33145
Facility #1 Miami Springs Florida 33166
Facility #1 Naples Florida 34102
Facility #1 Ocala Florida 34471
Facility #1 Orlando Florida 32806
Facility #1 Palm Beach Gardens Florida 33410
Facility #1 St. Petersburg Florida 33713
Facility #1 Sunrise Florida 33351
Facility #3 Tampa Florida 33609
Facility #1 Tampa Florida 33613
Facility #2 Tampa Florida 33613
Facility #1 The Villages Florida
Facility #2 Atlanta Georgia 30308
Facility #1 Atlanta Georgia 30329
Facility #1 Columbus Georgia 31909
Facility #1 Decatur Georgia 30033
Facility #1 Chicago Illinois 60640
Facility #1 Elk Grove Village Illinois 60007
Facility #1 Elkhart Indiana 46514
Facility #1 Indianapolis Indiana 46202
Facility #1 Wichita Kansas 67214
Facility #1 Lexington Kentucky 40504
Facility #1 Boston Massachusetts 02115
Facility #2 Boston Massachusetts 02118
Facility #1 Burlington Massachusetts 01805
Facility #1 Newton Massachusetts 02459
Facility #1 Ann Arbor Michigan 48105-2945
Facility #1 East Lansing Michigan
Facility #1 Farmington Hills Michigan 48334
Facility #1 Lansing Michigan 48824
Facility #1 West Bloomfield Michigan 48322
Facility #1 St Louis Missouri 63118
Facility #1 Eatontown New Jersey 07724
Facility #1 Toms River New Jersey 08755
Facility #1 Albany New York 12206
Facility #1 Amherst New York 14226
Facility #1 Latham New York 12110
Facility #1 New York New York 10016
Facility #2 New York New York 10021
Facility #1 Rochester New York 14620
Facility #2 Rochester New York 14623
Facility #1 Charlotte North Carolina 28211
Facility #1 Centerville Ohio 45459
Facility #1 Oklahoma City Oklahoma 73112
Facility #2 Oklahoma City Oklahoma 73116
Facility #2 Portland Oregon 97210
Facility #1 Portland Oregon 97239
Facility #1 Abington Pennsylvania 19001
Facility #1 Jenkintown Pennsylvania 19046
Facility #1 East Providence Rhode Island 02914
Facility #1 Knoxville Tennessee 37920
Facility #1 Austin Texas 78757
Facility #1 Dallas Texas 75214
Facility #2 Dallas Texas
Facility #1 Houston Texas 77074
Facility #1 San Antonio Texas 78229
Facility #2 San Antonio Texas 78229
Facility #3 San Antonio Texas 78229
Facility #1 Bennington Vermont 05201
Facility #1 Richmond Virginia 23294
Facility #1 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01767311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2026 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01767311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →